XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share-Based Compensation Expense The Company recorded stock-based compensation expense in the following categories of its consolidated statements of operations and balance sheets (in thousands):

 

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

Engineering services

 

$

8,832

 

 

$

5,026

 

General and administrative costs

 

 

4,457

 

 

 

4,365

 

BlueWalker 3 satellite - construction in progress(1)

 

 

-

 

 

 

(45

)

Total

 

$

13,289

 

 

$

9,346

 

 

(1)
For the year ended December 31, 2022 stock-based compensation was reversed as a result of forfeiture of options previously provided to a
supplier.
Schedule of Stock Options Act

The following table summarizes the Company’s option activity for the year ended December 31, 2023:

 

 

Options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2022

 

 

10,767,799

 

 

$

0.83

 

 

 

5.87

 

 

$

42,994,264

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

 

(2,972,581

)

 

 

0.08

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(24,797

)

 

 

3.35

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

7,770,421

 

 

$

1.11

 

 

 

5.76

 

 

$

38,262,071

 

Options exercisable as of December 31, 2023

 

 

5,960,866

 

 

$

0.90

 

 

 

5.59

 

 

$

30,552,352

 

Vested and expected to vest at December 31, 2023

 

 

6,391,004

 

 

$

1.24

 

 

 

5.66

 

 

$

30,639,437

 

Schedule of Unvested Option Activity

The following table summarizes the Company’s unvested option activity for the year ended December 31, 2023:

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

2,645,240

 

 

$

0.80

 

Granted

 

 

-

 

 

 

-

 

Vested

 

 

(814,415

)

 

 

0.76

 

Forfeited

 

 

(21,270

)

 

 

2.25

 

Unvested at December 31, 2023

 

 

1,809,555

 

 

$

0.80

 

Schedule of Unvested Restricted Stock Units Activity

The following table summarizes the Company’s unvested restricted stock unit activity for the year ended December 31, 2023:

 

 

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

 

 

3,246,220

 

 

$

9.65

 

Granted

 

 

 

 

661,348

 

 

 

4.96

 

Vested

 

 

 

 

(822,275

)

 

 

10.10

 

Forfeited

 

 

 

 

(205,875

)

 

 

8.69

 

Unvested at December 31, 2023

 

 

 

 

2,879,418

 

 

$

8.51

 

Employee Stock Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Unvested Option Activity

The following table summarizes the Company’s unvested option activity for the year ended December 31, 2023:

 

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value

 

Unvested at December 31, 2022

 

 

2,959,596

 

 

$

4.26

 

Granted

 

 

288,300

 

 

 

2.53

 

Vested

 

 

(1,052,229

)

 

 

4.22

 

Forfeited

 

 

(465,758

)

 

 

4.40

 

Unvested at December 31, 2023

 

 

1,729,909

 

 

$

3.96

 

Schedule of Option Award Estimated Using a Black-Scholes Option-pricing Model Assumptions

The fair value of each stock option is estimated on the date of grant using a Black-Scholes option-pricing model, with the assumptions used for the years ended December 31, 2023 and 2022, presented on a weighted average basis:

 

 

 

Year ended December 31, 2023

 

 

Year ended December 31, 2022

 

Exercise price

 

$

5.28

 

 

$

9.20

 

Fair market value

 

$

2.53

 

 

$

4.16

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Expected term (in years)

 

 

6.1

 

 

 

6.1

 

Expected volatility

 

 

43.81

%

 

 

42.13

%

Weighted-average risk-free rate

 

 

3.75

%

 

 

3.24

%

 

Schedule of Stock Options Activities

The following table summarizes the Company’s option activity under the 2020 Plan for the year ended December 31, 2023:

 

 

 

Options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2022

 

 

3,697,649

 

 

$

9.71

 

 

 

9.07

 

 

$

(18,077,872

)

Granted

 

 

288,300

 

 

 

5.28

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(672,869

)

 

 

9.26

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

3,313,080

 

 

$

9.27

 

 

 

8.29

 

 

 

(10,726,391

)

Options exercisable as of December 31, 2023

 

 

1,583,171

 

 

$

9.75

 

 

 

7.70

 

 

 

(5,883,276

)

Vested and expected to vest at December 31, 2023

 

 

3,313,080

 

 

$

9.27

 

 

 

8.29

 

 

 

(10,726,391

)